Selective internal radiation therapy with QuiremSpheres for treating unresectable advanced hepatocellular carcinoma

  • Technology appraisal guidance
  • TA985
  • Published: 

This guidance has been withdrawn because the simple discount patient access scheme for QuiremSpheres has been withdrawn.